As of 2025-09-16, the Relative Valuation of Chemours Co (CC) is (10.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.26 USD, the upside of Chemours Co based on Relative Valuation is -163.5%.
The range of the Relative Valuation is (34.62) - 19.41 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.3x - 15.5x | 14.2x |
| Forward P/E multiples | 13.6x - 16.2x | 15.0x |
| Fair Price | (34.62) - 19.41 | (10.96) |
| Upside | -300.6% - 12.5% | -163.5% |
| Date | P/E |
| 2025-09-15 | -6.15 |
| 2025-09-12 | -5.97 |
| 2025-09-11 | -5.97 |
| 2025-09-10 | -5.80 |
| 2025-09-09 | -5.94 |
| 2025-09-08 | -5.79 |
| 2025-09-05 | -5.58 |
| 2025-09-04 | -5.38 |
| 2025-09-03 | -5.34 |
| 2025-09-02 | -5.46 |
| 2025-08-29 | -5.49 |
| 2025-08-28 | -5.37 |
| 2025-08-27 | -5.43 |
| 2025-08-26 | -5.41 |
| 2025-08-25 | -5.42 |
| 2025-08-22 | -5.48 |
| 2025-08-21 | -5.04 |
| 2025-08-20 | -5.11 |
| 2025-08-19 | -5.36 |
| 2025-08-18 | -5.33 |
| 2025-08-15 | -5.21 |
| 2025-08-14 | -5.37 |
| 2025-08-13 | -5.22 |
| 2025-08-12 | -4.43 |
| 2025-08-11 | -4.16 |
| 2025-08-08 | -4.34 |
| 2025-08-07 | -4.34 |
| 2025-08-06 | -4.28 |
| 2025-08-05 | -4.50 |
| 2025-08-04 | -4.35 |
| 2025-08-01 | -4.10 |
| 2025-07-31 | -4.27 |
| 2025-07-30 | -4.47 |
| 2025-07-29 | -4.84 |
| 2025-07-28 | -4.95 |
| 2025-07-25 | -5.05 |
| 2025-07-24 | -4.99 |
| 2025-07-23 | -5.21 |
| 2025-07-22 | -4.96 |
| 2025-07-21 | -4.84 |
| 2025-07-18 | -4.83 |
| 2025-07-17 | -4.87 |
| 2025-07-16 | -4.72 |
| 2025-07-15 | -4.69 |
| 2025-07-14 | -4.81 |
| 2025-07-11 | -4.93 |
| 2025-07-10 | -5.01 |
| 2025-07-09 | -4.91 |
| 2025-07-08 | -4.86 |
| 2025-07-07 | -4.43 |